Cuu Long Pharmaceutical JSC (HOSE:DCL)

Vietnam flag Vietnam · Delayed Price · Currency is VND
36,900
-400 (-1.07%)
At close: Apr 28, 2026
57.02%
Market Cap 2.70T
Revenue (ttm) 1.32T
Net Income (ttm) 19.52B
Shares Out 73.04M
EPS (ttm) 267.00
PE Ratio 138.20
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 588,407
Average Volume 966,032
Open 37,100
Previous Close 37,300
Day's Range 36,600 - 37,600
52-Week Range 20,850 - 62,800
Beta 0.63
RSI 23.15
Earnings Date Apr 24, 2026

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antihistamine, musculoskeletal, dermatology, analgesics and antipyretics, antibiotics, analgesics and anti-inflammatories, respiratory, gastrointestinal, cardiovascular, vitamins and minerals, and nervous medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, pharmac... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 880
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DCL
Full Company Profile

Financial Performance

In 2025, HOSE:DCL's revenue was 1.32 trillion, an increase of 1.13% compared to the previous year's 1.31 trillion. Earnings were 19.52 billion, a decrease of -62.16%.

Financial Statements

News

There is no news available yet.